Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Crash on 405 Freeway Near Mulholland Drive


Motorcycle, Tesla Collide in Los Angeles Accident

Motorcycle Accident 6

Los Angeles, CA (October 1, 2019) – A motorcyclist was injured in a crash in Los Angeles. The accident occurred on the morning of October 1 on the 405 Freeway.

A motorcycle and a Tesla Model 3 collided on the southbound 405 Freeway, near Mulholland Drive. The motorcycle rider was found lying on the ground. Paramedics tended to the injured motorcyclist.

#Los Angeles

#90077


October 17, 2019

Crash at W. Main Street and N. Morgan Road Causes Minor Injuries

Big Rig, Car Involved in Turlock Accident Turlock, CA (October 16, 2019) – A ...


October 21, 2019

9 Injured in Crash at Sherman Way and De Soto Avenue

WSS Store Flooded in Multi-Vehicle Accident in Los Angeles Los Angeles, CA (Oct...


November 5, 2019

2 Injured in Crash at Magic Mountain and McBean Parkways

2 Vehicles Collide in Santa Clarita Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.